The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA's) MedWatch program (800-FDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with our readers. Write to Dr. Mancano at ISMP, 200 Lakeside Drive, Suite 200, Horsham, PA 19044 (phone: 215-707-4936; e-mail: mmancano@temple.edu). Your report will be published anonymously unless otherwise requested. This feature is provided by the Institute for Safe Medication Practices (ISMP) in cooperation with the FDA's MedWatch program and Temple University School of Pharmacy. ISMP is an FDA MedWatch partner.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278909PMC
http://dx.doi.org/10.1310/hpj5201-13DOI Listing

Publication Analysis

Top Keywords

adverse drug
8
drug reactions
8
fda's medwatch
8
medwatch program
8
ismp
4
ismp adverse
4
reactions acute
4
acute disseminated
4
disseminated intravascular
4
intravascular coagulation
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!